<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS94378</article-id>
<article-id pub-id-type="doi">10.1101/2020.08.26.267781</article-id>
<article-id pub-id-type="archive">PPR206925</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Compositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Teng</surname>
<given-names>Xufei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Qianpeng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Zhao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Yuansheng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niu</surname>
<given-names>Guangyi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Jingfa</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhang</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Shuhui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>China National Center for Bioinformation, Beijing 100101, China</aff>
<aff id="A2">
<label>2</label>National Genomics Data Center &amp; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China</aff>
<aff id="A3">
<label>3</label>University of Chinese Academy of Sciences, Beijing 100049, China</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Correspondence: <email>songshh@big.ac.cn</email> (Song S), <email>zhangzhang@big.ac.cn</email> (Zhang Z), <email>junyu@big.ac.cn</email> (Yu J).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>01</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>30</day>
<month>08</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">COVID-19 and its causative pathogen SARS-CoV-2 have rushed the world into a staggering pandemic in a few months and a global fight against both is still going on. Here, we describe an analysis procedure where genome composition and its variables are related, through the genetic code, to molecular mechanisms based on understanding of RNA replication and its feedback loop from mutation to viral proteome sequence fraternity including effective sites on replicase-transcriptase complex. Our analysis starts with primary sequence information and identity-based phylogeny based on 22,051 SARS-CoV-2 genome sequences and evaluation of sequence variation patterns as mutation spectrum and its 12 permutations among organized clades tailored to two key mechanisms: strand-biased and function-associated mutations. Our findings include: (1) The most dominant mutation is C-to-U permutation whose abundant second-codon-position counts alter amino acid composition toward higher molecular weight and lower hydrophobicity albeit assumed most slightly deleterious. (2) The second abundance group includes: three negative-strand mutations U-to-C, A-to-G, G-to-A and a positive-strand mutation G-to-U generated through an identical mechanism as C-to-U. (3) A clade-associated and biased mutation trend is found attributable to elevated level of the negative-sense strand synthesis. (4) Within-clade permutation variation is very informative for associating non- synonymous mutations and viral proteome changes. These findings demand a bioinformatics platform where emerging mutations are mapped on to mostly subtle but fast-adjusting viral proteomes and transcriptomes to provide biological and clinical information after logical convergence for effective pharmaceutical and diagnostic applications. Such thoughts and actions are in desperate need, especially in the middle of the <italic>War against COVID-19.</italic>
</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2</kwd>
<kwd>Nucleotide composition</kwd>
<kwd>Mutation spectrum</kwd>
<kwd>Viral replication</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">COVID-19, a novel pneumonia epidemic causing an outbreak first identified and reported in Dec 2019 from China [<xref ref-type="bibr" rid="R1">1</xref>] and subsequently spread to other countries swiftly, has been posing enormous professional, economic, and political challenges to global health services and hazardous control systems. As of 12 June 2020, there have been 7,410,510 confirmed cases and 418,294 deaths reported [<xref ref-type="bibr" rid="R2">2</xref>]. COVID-19 is of great contagious (even at incubation period) and has lower mortality to our current understanding [<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>]. The novel betacoronavirus identified through <italic>de novo</italic> sequencing from patients with COVID-19 is designated as “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)” by International Committee on Taxonomy of Viruses (ICTV) [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>].</p>
<p id="P3">The recent threats from SARS-CoV-2, SARS-CoV, and MERS-CoV are different from those of earlier human coronaviruses (CoVs), including alphacoronaviruses, such as hsa-CoV-229E, hsa-CoV-NL63, hsa-CoV-OC43 and hsa-CoV-HKU1 [<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>], in at least two aspects. First, the recent groups of betacoronaviruses appears to come more frequently in the past two decades as compared to the early comers where new members may be discovered as technology become more efficient and accurate [<xref ref-type="bibr" rid="R11">11</xref>]. The current SARS-CoV-2 is also different from both SARS-CoV and MERS-CoV as its genome composition is most closely for “living with mammals and humans”, where a much lower G+C content has been evolved and is closer to two other human-adapted CoVs, hsa-CoV-229E and hsa-CoV-OC43, than its members of the recent group, although it shares higher sequence identities with the two new CoVs, 80.12% and 60.06%, respectively [<xref ref-type="bibr" rid="R11">11</xref>]. Second, it has been infecting far larger populations, as compared to the two recent outbreaks, with variable yet more complex symptoms [<xref ref-type="bibr" rid="R12">12</xref>]. The causative factors of such an unprecedented disease potency remain to be elucidated for the days and months to come [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R7">7</xref>].</p>
<p id="P4">Genomes of coronaviruses mutate in a unique way where signatures of DNA pairing and repairing mechanisms are absent completely, and instead, they possess an error-prone synthesis of single-stranded full or partial genomic sequences by multi-component membrane-associated enzymatic structure known as the replicase-transcriptase complexes (RTCs) and doublemembrane vesicles (DMVs) although they do have certain enzymatic activity resembling repair mechanisms of cellular organisms, such as proofreading [<xref ref-type="bibr" rid="R13">13</xref>], and other possible cellular mechanisms may also be involved, such as RNA editing as recently proposed [14,15]. Here we define a series of displays to understand compositional dynamics or variability that ultimately interconnects to proteomic variability including RTCs and DMVs (of course also other omics) through the organization of the genetic code [<xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R19">19</xref>]. We subsequently compare SARS-CoV-2 with other human CoVs for between-population variation analysis to point out that it is not a direct descendant of the previous human-infecting CoVs. We finally make efforts to decipher the SARS-CoV-2 clades for its variations and suggest that what we have seen now are not the natural picture of the pandemics and the missing-links are not among human populations but the wildlife close to human habitats in Southeast Asian territories, including islands and shorelines, not just limited to bats and pangolins. We also show how to examine clade-associated permutation variations and relate genetic variations to protein structures and phenotypic data. Nailing down a single animal of human origin of the virus will not be the goals of this genomics-based study but to provide information for smarter drug design, effective vaccine development, accurate diagnostics.</p>
</sec>
<sec id="S2" sec-type="results | discussion">
<title>Results and Discussion</title>
<sec id="S3">
<title>Compositional dynamics and its parameters are essential and useful features for evaluating the evolutionary status and molecular mechanisms of SARS-CoV-2 towards pandemics</title>
<p id="P5">RNA genomics is very different from DNA genomics in several ways [<xref ref-type="bibr" rid="R11">11</xref>]. First, in the RNA genome, the A:U basepair is actually 2 Daltons heavier than that of the G:C basepair due to a larger molecular weight of uridine, whereas in the DNA genome the GC pair is a single Dalton heavier than that of the A:T basepair. In CoVs, the G+C content is actually in a trend of reducing so that the virus is in turn becoming heavier due to the increased U content [<xref ref-type="bibr" rid="R11">11</xref>]. Second, single-stranded RNA genomes are synthesized without stable double-stranded intermediates that allow mismatch repair albeit existence of short and extremely rare doublestranded RNA fragments involved in interference-based immunity [<xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R21">21</xref>]. Third, the existence of Wobble basepairing for secondary structures is of essence for operational functions of all RNA molecules in addition to genetic information inheritance [<xref ref-type="bibr" rid="R22">22</xref>]. That said, we can now look at how the RNA genome of SARS-CoV-2 and related CoVs take advantage of these RNA-centric features.</p>
<p id="P6">As a positive-sense single-stranded RNA virus, SARS-CoV-2 has a genome length of ~29903 nucleotides (nt) (GenBank: NC_045512.2). It encodes two large polypeptides, ORF1a and ORF1b, along with other 15 non-structure proteins (nsps; <xref ref-type="fig" rid="F1">Figure 1A</xref>). In order to propagate and complete the life cycle, its positive-sense genome is first replicated to synthesize fulllength negative-sense antigenomes and 10 shorter subgenomes (sgRNAs), executed by RTCs and DMVs, and the sgRNAs encode four structural proteins (S, spike; E, envelope; M, membrane; and N, nucleocapsid) and six accessory proteins (ORF3a, ORF6, ORF7a, ORF7b, ORF8, and ORF10) arranged among structural proteins depending on the current annotation (GenBank: NC_045512.2).</p>
<p id="P7">Traditionally, we use three basic plots to display composition dynamics based on primary genomic parameters over genome length: G+C contents at three codon positions (GC1, GC2 and GC3); purine content (A+G content); and GC skew (the content of (G-C)/(G+C)). Here, we use a 300-nt sliding window with a step size of 21 nt, as the majority of viral sequences are protein-coding, to illustrate the dynamics of the composition parameters, G+C and purine contents (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The G+C content of SARS-CoV-2 varies in a narrow but significant window of 18.00% (31.67%-49.67%) and the purine content in a slightly narrower window of 15.50% (41.67%-57.17%) in average over the entire genome length. The GC skew of the SARS-CoV-2 genome indicates the G+C ratio is relatively higher in structural proteins than ORF1ab and this imbalance is a signature of distinct mutational biases caused by viral replication machinery, known as RTCs. It is also variable as a frequent shift toward negative values are often seen in individual ORFs and defined proteins. Such minor anomalies suggest either recombination or selection events, which are species- or isolate-specific. The differences become obvious when SARS-CoV-2 is compared to the closely-related bat and pangolin CoVs (raf-betaCoV-RaTG13 and mja-betaCoV-P4L; <xref ref-type="supplementary-material" rid="SD1">Figure S1A and S1B</xref>), and the authentic within-species variation is exemplified when SARS-CoV and MERS-CoV are matched up with civets and camels in similar parameters, respectively (<xref ref-type="supplementary-material" rid="SD1">Figure S1C, S1D, S1E and S1F</xref>). The G+C content of different codon positions is also very informative, where GC3 is very characteristic of mutation pressure as it is obvious that all GC3 values of the viral proteins are biased toward lower G+C contents. GC3-associated mutations often reflect directional mutation patterns as observed strongly in certain lineages of plants and warm-blooded vertebrates as negative gradients from the transcription starts, and such trends are attributable to a special DNA repair mechanism, transcription-coupled DNA repair [<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref>]. The notion here is to remind ourselves that transcription-centric mutations may be accounted for some of the mutation events in RNA viruses in their replication-transcription processes. Occasional twists from the trend often indicate selective pressures, such as in the case of S, M, and N proteins, and weaker GC3 or stronger GC1 or GC2 selections. Codon-associated G+C content trends are less informative for small ORFs, such as the case of ORF10. Most of the sequence signatures are indicative rather than proven functional relevance of proteins but very useful for providing clues of sequence anomaly.</p>
<p id="P8">For studying RNA viral genomes, in addition to previously-defined parameters, we need to introduce the concept of single nucleotide (A, U, G and C) contents at three codon positions (such as U1, U2 and U3 for uridines) (<xref ref-type="fig" rid="F2">Figure 2</xref>) and to plot out compositional dynamics for positive-sense or the genome and negative-sense strands, which include both templates for synthesizing new positive-sense genomes or antigenome and subgenomes. All viral mRNAs are transcribed from an antigenome and other 9 subgenomes (<xref ref-type="fig" rid="F2">Figure 2B</xref>). For compositional dynamics of RNA genomes, uridine is the star nucleotide, and A+U content becomes the most important. Just for the sake of convenience, we would like to keep the concept of G+C content since it has been known to be a useful variable for DNA compositional dynamics [<xref ref-type="bibr" rid="R26">26</xref>] and provide an approximation for less selected nucleotide position. For both DNA and RNA viruses, this variable G+C content remains similar to their hosts mostly, except those that are not well adapted to their hosts, such as SARS-CoV or MERS-CoV (<xref ref-type="supplementary-material" rid="SD1">Figure S2A</xref>; [<xref ref-type="bibr" rid="R11">11</xref>]).</p>
<p id="P9">As shown in a phylogenetic tree constructed based on 15 representative coronaviruses (<xref ref-type="fig" rid="F2">Figure 2A</xref>), the nucleotide content of SARS-CoV-2 is most similar to those of raf-betaCoV-RaTG13 and mja-betaCoV-P4L, which are considered to be distantly related but most closely related so-far-found host of SARS-CoV-2. Other known zoonotic and corresponding human counterpart CoVs are rather close to each other in their compositions. We have made a few interesting observations here. First, the single nucleotide content is more informative than G+C content, especially for genome analysis on RNA viruses. The former points out only how G+C content drifts toward richness or poorness but the latter narrows it down to single nucleotide effect. In our case, U stands out at cp3, which alters the overall nucleotide contents, and it drives the G+C content so low that even its partner A content has gone to the same extremity, so that the low G+C content is a result of both lowering U and A. If the organization principles are considered here, half of the codons are not sensitive to cp3 changes, and most of them are smaller amino acids (<xref ref-type="supplementary-material" rid="SD1">Figure S2B</xref>; [<xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R19">19</xref>]). Second, at the cp1, G and C contents are both pulled apart toward extremity but not A or U, while the two pyrimidines and two purines appear stretched to separate directions; these trends suggest strong selective pressure at the first codon position over the entire genome. It is indeed that cp1 codons shoulder the most mutation pressures since they fall into all 4 negative-sense strand permutations (known as R1-derived permutations, C-to-U, G-to-A, U-to-C and A-to-G). Third, the cp2 contents are most rowflipping changes referenced to the genetic code organization [<xref ref-type="bibr" rid="R18">18</xref>]. These alterations are very useful for alternating chemical characteristics between related amino acids, and in terms of flexibility, cp2 codons are less stringent than cp3 but more flexible than cp1. The balancing power becomes more obvious when ORFs or proteins are examined individually for their composition dynamics (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Finally, it is conclusive that the more similar the CoVs in composition dynamic parameters, the closer they are genetically and phylogenetically in principle. However, primary parameters, such as G+C and purine contents are necessary but may not be sufficient. For instance, there has been a CoV genome isolate from a wild vole captured in northeastern China, whose G+C and purine contents overlap with SARS-CoV-2 completely (Rodent coronavirus isolate RtMruf-CoV-2/JL2014; 0.38, 0.496; [<xref ref-type="bibr" rid="R27">27</xref>]) but its genome sequence is different (sharing 61.87% identity with SARS-CoV-2). Therefore, we have yet to find a within-population immediate animal host of SARS-CoV-2 albeit best similarity of composition dynamics seen among them.</p>
<p id="P10">Our subsequent study is focused on composition dynamics within CoV genomes. It is interesting to see uniformity among all codon position contents of all CoV genomes, increased G+C content from antigenomes to subgenomes. However, this trend is an illusion where the real trend is the lower G+C content of antigenomes but higher G+C contents of subgenomes due to stronger selection over structural proteins. This observation becomes clearer when all ORFs and proteins are scrutinized one by one (<xref ref-type="fig" rid="F1">Figure 1C</xref> and <xref ref-type="supplementary-material" rid="SD1">Figures S1</xref>). SARS-CoV-2 has an exceptionally short subgenome 9 (sg9) which only contains ORF10, but we have no evidence that it is either functional or non-functional. These results collectively remind us that SARS-CoV-2 and its two most-closely-related CoVs, unlike in the case of many other known CoVs, have a unique genome composition and similar dynamics to the early-adapted human CoVs [<xref ref-type="bibr" rid="R11">11</xref>], and CoV-borne bats and other mammals may already coexist with ability to jump on to humans and domestic animals but only limited by environmental and geographic constraints.</p>
</sec>
<sec id="S4">
<title>Mutation spectrum is composed of permutations that are distinct according to their strand specificity, order of synthesis, and ratio of positive-sense vs. negative-sense strands during propagation</title>
<p id="P11">We use 12 permutations to represent directional mutations and classify them according to strand-specific replication mechanisms (<xref ref-type="fig" rid="F3">Figure 3</xref>) since they are readily related to codons [<xref ref-type="bibr" rid="R11">11</xref>] (<xref ref-type="supplementary-material" rid="SD1">Figure S2B</xref>). From a total of 5,054 point mutations, 1,416, 1,497, and 2,141 mutations fall on codon position 1, 2, and 3, respectively. The permutations are categorized into R1 (C-to-U, G-to-A, U-to-C and A-to-G), R2 (C-to-A, U-to-G, A-to-C and G-to-U), and R12 (C-to-G, U-to-A, A-to-U and G-to-C) derived according to their occurrence tailored to RTC-directed strand synthesis: R1 from the first negative-sense strand, R2 from the subsequent positive-sense strand, and R12 from R1 plus R2. The most abundant permutations are four R1 permutations and one R2 permutation, G-to-U (<xref ref-type="fig" rid="F3">Figure 3A and 3B</xref>). What have we shown here is how sensitive are nucleotide content of cp3 to selective pressure, and most cp3 permutations disappear except the R2 G-to-U permutations at cp3, where all changes are transversions and more than half of all codons (all pro-diversity changes) are sensitive to them. Similar results are observed in our analysis on SARS-CoV and MERS-CoV (<xref ref-type="supplementary-material" rid="SD1">Figure S3A and S3B</xref>). There are slightly different patterns among SARS-CoV and MERS-CoV and their within-population mammals from the SARS-CoVs and close relatives, the higher U-to-C permutations. The predominate C-to-U represents a driving force of variation, and it manifests why both G+C and A+G contents of SARS-CoV-2 appear relatively lower against MERS-CoV and SARS-CoV and even more when compared to human CoVs, such as 229E and OC43 (<xref ref-type="supplementary-material" rid="SD1">Figure S2A</xref>).</p>
<p id="P12">Since most cp1 and cp2 related permutations are sensitive to selection, we have examined how individual permutations correlated to codon rearrangements in the two halves tables: prodiversity and pro-robustness (<xref ref-type="fig" rid="F3">Figure 3C and 3D</xref>) [<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R17">17</xref>]. Only two examples, C-to-U and A-to-G, are shown here and the rest are summarized in <xref ref-type="supplementary-material" rid="SD1">Figure S3C</xref>. Several observations are worthy of in-depth discussion. First, it is known that three amino acids and their codons are unique in balancing one of two purine-sensitive halves; they are Leu (leucine), Arg (arginine), and Ser (serine) [<xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R19">19</xref>]. The most abundant amino acid in protein coding sequences (known as codon usage) is Leu and it buffers C-to-U|U-to-C mutations at cp1. Arg and Ser are also abundant as they both are 6-fold degenerate codons; Arg appears buffering A-to-G|G-to-A at cp1 and Ser carries two: U-to-A|A-to-U at cp1 and G-to-C|C-to-G at cp2. Second, amino acid exchanges are permissive in physiochemical properties [<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref>]. For instance, Ser has a very similar size to Ala (alanine) so that G+C content increase is buffered by the two amino acids as G-to-U|U-to-G permutations. Third, other examples are codon alterations among hydrophobic amino acids as they are mostly C-to-U changes at cp2 among those in the prorobustness half. The overall effects are displayed together in <xref ref-type="fig" rid="F3">Figure 3D</xref>. It is rather clear that changes toward lower G+C content and near the balanced purine content are both beneficial for CoVs, especially SARS-CoV-2, as these changes are pro-diversity, in favor of larger and more hydrophilic amino acids.</p>
</sec>
<sec id="S5">
<title>Clade-associated biased mutation trend in SARS-CoV-2 revealed physiochemical features of replication machinery</title>
<p id="P13">Difficulties for analyzing CoV genomes are multifold. Since we have yet to identify the natural hosts and mammalian intermediate hosts, if there is any, this massive dataset has to be analyzed by stratifying the data into structured and non-structured clades; the former can be analyzed first and the rest await further ideas. The next is even more troublesome. Assuming that we have 5 or more genome sequences per CoV isolate and variations identified among them are still a miniscule fraction of the total virions produced in a patient body (medians and means of variations per CoV isolate among C01 to C09, see <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>), since the viral load per patient sample, such as sputum [<xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R29">29</xref>], is equivalent to a 5-person or more sampling of the entire human population on earth, 1 out of 10<sup>9</sup>. Even so, we have still been able to find shared variations among patient samples occasionally and even more lucky to have some clade structures, by and large due to the relatedness of the patients in the transmission network. Finally, we have to admit that many assumptions have to be made about these samples and their genome sequences above sequence and assembly errors for phylogeny and genetic studies.</p>
<p id="P14">Nevertheless, we have constructed a somewhat stable phylogenetic tree-and-branch structure for further analysis (<xref ref-type="fig" rid="F4">Figure 4A</xref>). It is composed of 8 monophyletic clades and 1 non-monophyletic clade based on both orders of sample collection date and highly-shared mutations. Among the clades, C02 shares two landmark mutations, C8782U in ORF1ab and U28144C in ORF8, and earlier date (2019/12/30). C04 shares three more mutations (C17747U, A17858G, and C18060U in ORF1ab) than what C02 have, and a late collection date (2020/02/20). Clades C03, C05, and C07 are also distinguishable by some major mutations, so are C06, C08, and C09; the latter clades are clustered together based on four shared and other clade-associated mutations. The leftover large number of isolates that lack all landmark mutations are grouped into C01, which have the earliest collection date on 2019/12/24. According to the literature and our discussion, we have further grouped the clades into three clusters, S (C02 and C04), G (C06, C08 and C09), and L (all the rest) since phylogeny shows clear divergence among them. We have several notions about this imperfect hierarchical structure. First, our within- and between-clade analysis of high major allele frequency (MAF) variations reveals that some clade-associated signature mutations are also shared among clades. For instance, C14805U in ORF1ab and A24034G in Cluster S have recurred in other clades of different clusters, which are excellent landmarks for subclade definition. Another notion is that higher MAF within-clade mutations (such as MAF&gt;0.2) are mostly non-synonymous mutations, indicating selection at work (<xref ref-type="supplementary-material" rid="SD1">Figure S4</xref>). Our neighbor-joining tree based on distances from 9 clades suggests that SARS-CoV-2 appears originated from multiple zoonotic reservoirs instead of a single direct ancestor (<xref ref-type="supplementary-material" rid="SD1">Figure S4</xref>). In addition, our classification rationales are largely in agreement with published reports [<xref ref-type="bibr" rid="R30">30</xref>]; for example, Cluster S is in accordance with previously defined S type [<xref ref-type="bibr" rid="R31">31</xref>] and Cluster G is in line with GISAID [<xref ref-type="bibr" rid="R32">32</xref>] defined the G clade. Cluster L is similar to the V and L clades combined, of GISAID. A maximum likelihood (ML) based unrooted phylogenetic tree is shown in <xref ref-type="supplementary-material" rid="SD1">Figure 4B</xref>.</p>
<p id="P15">To look for clade-associated compositional and functional features, we have first built a consensus sequence for each clade and subsequently calculated frequencies for each within-clade permutation (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>; <xref ref-type="fig" rid="F5">Figure 5A and 5B</xref>). A key assumption behind this is that certain functional mutations may have clade-specific effects on mutation spectrum, to close a loop where sequence mutations through genetic coding principles alter the viral proteome function. Our observations are of importance in establishing logics about compositional dynamics between nucleic acids and proteins. First, permutations among clades are indeed variable according to their proportions calculated from genome variants, and aside from 5 high-proportion permutations, 4 R1 and 1 R2 permutations, two other R2 and one R12 permutations appear also joining in, which are U-to-G and A-to-C, as well as A-to-U, respectively. Second, the variable permutations, where some may represent effect of mutation pressure and others may exaggerate selection pressure, are unique to clades and clade clusters. For instance, clade cluster S has the lowest G-to-U fraction as compared to those of L and G; in addition, among the S clades, C04 has the lowest value of G-to-U. Similarly, C03, C05, C06, C08, and C09 have relatively higher G-to-U permutations. Third, based on the disparity of permutations or simply mutation spectra, we have taken a rather radical step to assume RTC statuses in favor of either <italic>tight</italic> or <italic>loose</italic> statuses for binding to purines and pyrimidines (see <xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>). Since purines are larger than pyrimidines in size, the purine- or R-tight must be different from pyrimidine- or Y-tight. The results are strikingly predictable in that the R-tight status suggests a tighter binding pocket where a descending trend for tight permutations (C-to-U, G-to-U, and U-to-A) reverses into the opposite trend for Y-tight permutations. It indicates that the RTC structure and conformation variables may be definable in principle. At this point, we do not 302 have discrete definitions for these so-called tight statuses but the less trendy R-loose and Y-loose statuses also support a similar idea.</p>
<p id="P16">We have further examined the compositional subtleties among the clades and clusters with a focus on G+C and purine content variability as both contents appear drifting toward optima in SARS-CoV-2 and its relatives (<xref ref-type="fig" rid="F5">Figure 5C and 5D</xref>). Different clades exhibit distinct 307 compositional features and such dynamics are very indicative for the existence of feedback loops connecting RNA variables to protein variables. Two directions have to be advised for understanding these features albeit in absence of between-clade statistics. The first direction is driven by strong mutations, perhaps coupled to tight-loose switches in the catalytic pocket of RdRPs in RTCs. It is clear that except C01, the G or C06-C08-C09 cluster has the lowest G+C (0.37929, based on a C08 CoV sampled in Australia) and the lowest purine contents (0.49527, based on a C08 CoV collected in Bangladesh and a C09 CoV collected in England). Both lower G+C and purine contents are indicative of mutation pressure and signal this fast-evolving cluster of CoVs. Since this cluster has the largest collection of CoVs, it is also not surprising to see a more complex median diversification within clades (<xref ref-type="fig" rid="F5">Figure 5C and 5D</xref>). The second direction is the drive from selection or both selection and mutation in balance or imbalance, as well as in modes of fine-tuning or quick-escaping. Some results from our analyses are shown here for briefing purposes (<xref ref-type="fig" rid="F5">Figure 5E to 5G</xref>). For instance, G+C and purine contents at cp3 are informative for mutation drives and other measures are less clear cut (<xref ref-type="fig" rid="F5">Figure 5F</xref>), given the evidence that even MAFs among clades are not stably distributed among clades as lower MAF variations are rather sporadic and hard to analyze even binned into groups (data not shown).</p>
<p id="P17">Based on our clade and clade cluster analysis, it is tempting for us to speculate that there are plenty of rooms for further investigations into mutation spectra among large clades and even smaller clades or closely related individual CoV genomes for several reasons. First, all high-frequency MAFs should be identified and classified and these variations are candidates for highly selected mutations. Second, all within-clade minor but not rare alleles (less than 1/10,000), such as those of MAFs in a range of 0.01% to 10% should also be identified; they provide basis of within-clade sequence analysis. Third, all non-structured CoV genomes must be also classified based on shared variations, as they are not only valuable for within-clade but also for clade-cluster analyses since there is a large background of genome variations not yet brought into the databases.</p>
</sec>
<sec id="S6">
<title>Within-clade variations and their implications for future SARS-CoV surveillance</title>
<p id="P18">Within-clade compositional dynamics can also be very informative, especially for covering and predicting future functional changes, such as identifying mutated and diversified forms of CoVs for drug and vaccine designs. It is also of essence for nucleic acid-based diagnostics, such as clade-specific identifications. We are in a process of developing an interactive database and mutation-function predicting algorithms based on our results to interpret novel sequence variations in real time. Within-population variations are identified based on clade consensus sequence after alignment and extracted from datasets that have hundreds and thousands of genome sequences. The analysis of within-population variations relies on structured phylogeny and proportion change of permutations. The changes, based on functional relevance, can be classified into either copy number-related or RTC-specificity related, or sometimes both.</p>
<p id="P19">We have taken two steps to extract information in order to distinguish the underlining mechanisms (<xref ref-type="fig" rid="F6">Figure 6</xref>). In the first approach, we identify key mutations based on MAF of mutations with a consideration of relatively even distribution among subclades and name the subclades in a sequential order based on the absence of a subset (<xref ref-type="fig" rid="F6">Figure 6A</xref>). In the second step, we plot out permutations to track changes among subclades (<xref ref-type="fig" rid="F6">Figure 6B</xref>). For instance, clade C02 can be divided into 8 subclades and its variable permutation fractions are clearly recognizable. An immediate discovery is the trends of descending C-to-U, ascending A-to-G, and wavy G-to-U that initially goes up with A-to-G but rides down with C-to-U afterward.</p>
<p id="P20">Taking the two smaller clades, such as C03 and C05, as examples (<xref ref-type="fig" rid="F6">Figure 6D and 6E</xref>), we first find that their trends of permutation variables show opposite directions, where the increasing C-to-U accompanies with the decreasing G-to-U. A closer examination reveals that the increasing C-to-U in C03 is also accompanied by descending U-to-C. The only permutation showing an increasing trend in C03 is G-to-A. The take-home message from these trends is that RNA synthesis of this subclade is biased toward producing more negative-sense strands or its mutation spectrum exhibits increasing mutations generated during the negative-sense strand synthesis. Such analysis can be carried out continuously when more CoV genome data become available as other within-clade variations are not as informative as C03 vs. C05 (<xref ref-type="supplementary-material" rid="SD1">Figure S6</xref>).</p>
<p id="P21">Several precautions are worth noting in such analysis. The most noticeable weakness is the fact that we assume function-related mutations are discovered in our dataset. As we have proposed an analogy before, chances are slim, dozens out of millions or even billions. Furthermore, even if we see drastic changes in permutations and mutation spectra, the mutations we identified still need validation empirically and based on different data types or sources albeit rare and precious. Finally, most frequently encountered situations are those that multiple mutations exhibit cofounding effects for a phenotypically identified functional or structural feature, and undoubtedly, more and deep-sequencing data are still invaluable and irreplaceable.</p>
</sec>
</sec>
<sec id="S7" sec-type="conclusions">
<title>Conclusion</title>
<p id="P22">This COVID-19 pandemic provides once-in-a-lifetime opportunity for the fields of biomedicine and other life sciences to work together on it as many facets as possible albeit exchanging with lives and other massive losses. If lessons told, we had learned things in serious ways in the last two CoV epidemics and we did prepare ourselves with vaccines and medication since, we would not have suffered this much this time. If one assumes that the last two outbreaks of SARS-CoV and MERS-CoV came surely by chances, this time SARS-CoV-2 is here for real, and a worst-case scenario is that it may stay with us forever or until effective vaccination is developed. Nevertheless, it certainly will stay with us for quite a while for many reasons [<xref ref-type="bibr" rid="R11">11</xref>]. First, at least it and other within-population versions of coronaviruses will definitely come again because we have not been able to trace its origin and ways its transmission from the very beginning, neither the Wuhan outbreak nor the recent Beijing outbreak in China even guided with very strict quarantine roles and prompt action plans. Next, this particular virus, SARS-CoV-2, has evolved to a composition status where some of its natural yet genetically distant hosts or possible intermediate mammalian hosts have acquired similar status [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R34">34</xref>]. Furthermore, we do not yet have enough data to really map out the phylogenetic position that allows us to pinpoint its natural origin and human transmission routes.</p>
<p id="P23">The number one needs for us is data, genomic and clinical data, which should be as complete as possible and with characteristics including high-quality and high-coverage at single-molecule resolution. We currently have been acquiring genomic data and the specialized databases have collections over ten thousand non-redundant sequence variations, but still not enough to address more than a few possible functional changes of some key protein components [<xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R38">38</xref>], let alone understanding mutation-centric cellular mechanisms. Based on median and mean estimates, we have on average a mutation accumulation rate of half a dozen per patient. Although there have been data reported from single-molecule sequencing platform but they are low in coverage [<xref ref-type="bibr" rid="R39">39</xref>].</p>
<p id="P24">Our final notion is to emphasize the importance of analysis strategies and supporting platforms. Since questions always overwhelm what we can possibly address [<xref ref-type="bibr" rid="R40">40</xref>], prioritizing tasks are of essence together with choices of strategies. The first platform to be established concerns mutation-to-function interpretation, where we have present one in this report. Another to be considered is mathematic modeling, such as cellular and disease transmissions [<xref ref-type="bibr" rid="R41">41</xref>–<xref ref-type="bibr" rid="R46">46</xref>] and viral mutation-selection paradigm, for testing and evaluating different parameters and prioritizing what kind of data to be acquired with high priorities. In addition, cellular and molecular data, including different omics studies [<xref ref-type="bibr" rid="R47">47</xref>], all need to be incorporated into a COVID-19 knowledgebase, where information from multi-disciplinary studies are managed, organized, and mined.</p>
</sec>
<sec id="S8" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S9">
<title>SARS-CoV-2 and other related coronaviruses sequences</title>
<p id="P25">We used the public-available SARS-CoV-2 data collected worldwide among the major databases, including CNCB/NGDC [<xref ref-type="bibr" rid="R48">48</xref>], CNGBdb [<xref ref-type="bibr" rid="R49">49</xref>], GISAID [<xref ref-type="bibr" rid="R32">32</xref>], GenBank [<xref ref-type="bibr" rid="R50">50</xref>] and NMDC [<xref ref-type="bibr" rid="R51">51</xref>] on June 12<sup>th</sup>, 2020. To ensure authenticity and reliability, our datasets must meet the following criteria: (1) The genome sequence is labeled as complete that covers all coding regions of the reference genome (GenBank accession NC_045512.2). (2) It has no more than 15 uncertain bases that often substituted as “N”s. (3) It has no more than 50 degenerate bases that often labeled as discrete nucleotides. These high-quality genomes were aligned to the reference using MUSCLE (version 3.8.31) with default parameter settings [<xref ref-type="bibr" rid="R52">52</xref>]. Further analyses of SARS-CoV-2 and related CoV genomes are referenced to genome annotation of the same reference genome (NC_045512.2) and other information provided by the RefSeq database at NCBI.</p>
<p id="P26">Other closely related CoV genome sequences used include hsa-betaCoV-HKU1, hsa-betaCoV-OC43, ave-gamaCoV, mga-gamaCoV, smu-alphaCoV-WS, hsa-alphaCoV-229E, hsa-alphaCoV-NL63, taf-alphaCoV-NL63, MERS-CoV (from human and camel hosts), cdr-betaCoV-B73, SARS-CoV (from human and civet hosts), pla-betaCoV-SZ3 and raf-betaCoV-RaTG13 are retrieved from NCBI and mja-betaCoV-P4L are retrieved from NGDC. A full listing of our sequences dataset including virus genre, strain name, accession number and sources is provided in <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>.</p>
</sec>
<sec id="S10">
<title>Calculation of genomic composition parameters</title>
<p id="P27">We display several genomic composition dynamics and its parameters (G+C content, A+G content and GC skew) using different sliding windows. The first 300 nt are grouped as an initial window, and subsequent windows are uniformly shifted in a 21-nt step. Within these displays, the G+C contents referenced to the three codon positions of each open reading frame or ORF are measured by adjusting the sliding window according to the ORF lengths within viral genomes. As for ORFs longer than 2000 nt, a relatively large window size (300 nt) is adopted, and the step size is calculated via a custom formula <inline-formula>
<mml:math id="M1">
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>l</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>t</mml:mi>
<mml:msub>
<mml:mi>h</mml:mi>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:msup>
<mml:mi>F</mml:mi>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>300</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mn>600</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:mi>v</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>≤</mml:mo>
<mml:mi>v</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>≤</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula> where <italic>length<sub>ORF</sub>
</italic> denotes the length of ORF and <italic>vb</italic> varied from zero to two bases to make sure the window size is divisible by 3; for ORFs with a medium size (longer than 500 bases and shorter than 2000 nt), the window size is defined as <inline-formula>
<mml:math id="M2">
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>4</mml:mn>
</mml:mfrac>
<mml:mo>∗</mml:mo>
<mml:mi>l</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>t</mml:mi>
<mml:msub>
<mml:mi>h</mml:mi>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mi>F</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:mi>v</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>≤</mml:mo>
<mml:mi>v</mml:mi>
<mml:mi>b</mml:mi>
<mml:mo>≤</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>, while the step size is simply defined as 3 nt; as for those small ORFs (shorter than 500 nt) such as structural proteins, a constant 21-nt window size and 3-nt step size is used for calculating genomic composition frequency.</p>
<p id="P28">The criteria for choosing the representative CoV genome sequences for constructing a representative phylogenetic tree (<xref ref-type="fig" rid="F2">Figure 2</xref>) are multi-fold. First, we include all 7 humaninfecting coronaviruses for the analysis, which are SARS-CoV, SARS-CoV-2, MERS-CoV, hsa-alphaCoV-229E, hsa-betaCoV-OC43, hsa-betaCoV-HKU1, and hsa-alphaCoV-NL63 (a prefix hsa-standing for <italic>Homo sapiens</italic> was used to label the unfamiliar human-infecting CoVs). Second, we categorized all human-infecting, for simplicity, into 4 lineages: SARS-CoV-2, SARS-CoV, MERS-CoV, and the older human CoV lineages. Therefore, their related CoVs in the literature were also selected for the analysis, including a single closely-related CoVs for each lineage (based on sequence identity): SARS-CoV-related (pla-betaCoV-SZ3), MERS-CoV-related (cdr-betaCoV-B73), SARS-CoV-2 related (raf-betaCoV-RaTG13), and NL63-related (taf-alphaCoV-NL63; both species and CoV genera were labelled for clarity). Third, we also added more informative CoV genome sequences to enrich lineage-associated information, which are a pangolin coronavirus genome (mja-betaCoV-P4L) reported to be closed to SARS-CoV-2 and 3 non-beta-coronaviruses that infect animals (e.g., ave-gamaCoV from gamma-coronavirus genus and smu-alphaCoV-WS from alpha-coronavirus genus). Fourth, we only used complete protein-coding sequences from the CoVs to construct the phylogenetic tree and to calculate genome parameter contents. The sequences were aligned by using MUSCLE and the UPGMA tree was constructed by using MEGA-X [<xref ref-type="bibr" rid="R53">53</xref>]. The G+C content and single nucleotide content of each virus genome at three codon positions was also calculated. Subgenomes of SARS-CoV was obtained from Marra et al [<xref ref-type="bibr" rid="R54">54</xref>], and we annotated the subgenomes of SARS-CoV-2, mja-betaCoV-P4L, and raf-betaCoV-RaTG13 based on the annotation of NCBI (GenBank accession NC_045512.2). In addition, G+C and single nucleotide contents of the complete genome and its subgenomes of these four viruses at three codon positions were displayed to serve as sequence composition references.</p>
</sec>
<sec id="S11">
<title>Variation calling and categorization</title>
<p id="P29">All sequence variations are identified and categorized based on comparisons between the query and the reference genomes, and files were generated by using an in-hoc Perl scripts based on alignment results. The tailored annotation (gene, location and consequence on the protein sequence) of each variant is determined with VEP (version 99.0) [<xref ref-type="bibr" rid="R55">55</xref>]. Since a large number of 476 gaps and low-quality sequences at the 3' and 5' ends, variations (substitutions, insertions and deletions or indels) occurring 50 nt each at 5'- and 3'-ends of the genome are not considered. Since the higher quartile of variations per genome among SARS-CoV-2 populations is 9 (based on the 22,051 sequences we analyzed in this study), we filtered out the problematic sites that exceed 50 variations as compared to the reference genome. CoV genome sequences have at least one mutation are used in this study. A full listing of variations among coding regions identified in this study is provided in <xref ref-type="supplementary-material" rid="SD1">Table S4</xref>.</p>
<p id="P30">All continuously updated mutation files of the SARS-CoV-2 populations in variant call format (version 4.2) are deposited at the variation page of the 2019nCoVR database contributed by CNCB/NGDC (<ext-link ext-link-type="uri" xlink:href="https://bigd.big.ac.cn/ncov/variation/">https://bigd.big.ac.cn/ncov/variation/</ext-link>).</p>
</sec>
<sec id="S12">
<title>Mutation spectrum analysis</title>
<p id="P31">A mutation spectrum for within-population variations is composed of two lines of information; one concerns mutations that are referenced to a population consensus built based on the entire collection, and the other contains frequencies of all mutations and their directional changes, i.e., permutations. To reduce pitfalls of sequencing errors, we only selected mutations that occur more than twice in the whole collection of SARS-CoV-2 populations (clades or clade clusters that are often defined based on phylogenetic analysis). In theory, there are 16 possible permutations but 4 of them are unrecognizable so that 12 permutations (C-to-U, A-to-G, U-to-C, G-to-A, G-to-U, U-to-G, A-to-C, C-to-A, U-to-A, G-to-C, C-to-G and A-to-U) are there as an informative set. When the number of CoV genomes collected are limited, such as SARS-CoVs and MERS-CoVs, entire data sets are pooled together without clades. In our analyses on SARS-CoVs and MERS-CoVs (<xref ref-type="supplementary-material" rid="SD1">Figure S3A</xref>), we aligned sequences from these two lineages to their reference genomes (SARS-CoV: NC_004718.3; MERS-CoV: NC_019843.3) to call variations. When aligned on overlapping sequences, due to large deletions and additional ORFs, are encountered, we always choose the largest or only one of the ORFs to represent the segment, respectively. For example, in SARS-CoV lineage, if a mutation falls into the overlapping region of ORF9a (encoding the N protein) and ORF9b, we have only used the ORF9a annotations to avoid redundancy.</p>
</sec>
<sec id="S13">
<title>Phylogeny constructing</title>
<p id="P32">Given the scale of SARS-CoV-2 sequence collections, we focused on genomes with unique information contributing to phylogenetic analysis. First, mutations (including single-nucleotide substitution and indels) at frequencies equal or greater than 10 in between-clade or -population calls were selected. FastTree (version 2.1.11) [<xref ref-type="bibr" rid="R56">56</xref>] is used to construct maximum likelihood phylogeny based on 5,121 genomes that have met our criteria, and iTol [<xref ref-type="bibr" rid="R57">57</xref>], an interactive web server was employed for setting an unrooted format and annotating samples.</p>
<p id="P33">For <xref ref-type="supplementary-material" rid="SD1">Figure S4</xref>, the neighbor-joining method is used for constructing phylogeny from the Euclidean distance of the mutation frequency matrix of clades, and the tree was generated and visualized by R package phangorn [<xref ref-type="bibr" rid="R58">58</xref>] and ggtree [<xref ref-type="bibr" rid="R59">59</xref>].</p>
</sec>
<sec id="S14">
<title>Estimation of G+C and purine contents of genome sequences</title>
<p id="P34">G+C and purine (or A+G) contents of CoVs in general vary in a narrow range, and therefore, subtleties among the content changes have to be scrutinized with low-quality sequences excluded. A more sensitive approach is used in this study where two points are assumed; all genomes are full-length and variant alleles in coding sequences are the varied composition. The absolute frequencies of A+G and G+C content are defined as: <disp-formula id="FD1">
<label>(1)</label>
<mml:math id="M3">
<mml:mrow>
<mml:mi>G</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
<mml:mtext> </mml:mtext>
<mml:mi>A</mml:mi>
<mml:mi>G</mml:mi>
<mml:mtext> </mml:mtext>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>8954</mml:mn>
<mml:mo>+</mml:mo>
<mml:mn>5492</mml:mn>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mn>29903</mml:mn>
<mml:mo>−</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mi>e</mml:mi>
<mml:msub>
<mml:mi>l</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:msub>
<mml:mi>s</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula> and <disp-formula id="FD2">
<label>(2)</label>
<mml:math id="M4">
<mml:mrow>
<mml:mi>G</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
<mml:mtext> </mml:mtext>
<mml:mi>G</mml:mi>
<mml:mi>C</mml:mi>
<mml:mtext> </mml:mtext>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>5492</mml:mn>
<mml:mo>+</mml:mo>
<mml:mn>5863</mml:mn>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>G</mml:mi>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mn>29903</mml:mn>
<mml:mo>−</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mi>e</mml:mi>
<mml:msub>
<mml:mi>l</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:msub>
<mml:mi>s</mml:mi>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula> where 8,954, 5,492, 5,863, and 29,903 are the frequencies of A, G, C and total length of the SARS-CoV-2 reference, respectively. For any sequence compared with the reference, the <italic>Del<sub>alt</sub>
</italic> and <italic>Ins<sub>alt</sub>
</italic> measures the deleted and inserted nucleotides of this sequence, respectively, and that is why (<italic>Del<sub>alt</sub>
</italic> − <italic>Ins<sub>alt</sub>
</italic>) means the variation of sequence length. For all the variant sites in this sequence, (<italic>A<sub>alt</sub>
</italic> − <italic>A<sub>ref</sub>
</italic>) + (<italic>G<sub>alt</sub>
</italic> − <italic>G<sub>ref</sub>
</italic>) in Equation (<xref ref-type="disp-formula" rid="FD1">1</xref>) measures the number of A and G variations in compared sequence, <italic>A<sub>alt</sub>
</italic> and <italic>G<sub>alt</sub>
</italic> denote the number of nucleotides mutated to A or G while <italic>A<sub>ref</sub>
</italic> and <italic>G<sub>ref</sub>
</italic> represent the number of nucleotides mutated from A or G. Similarly, (<italic>G<sub>alt</sub>
</italic> − <italic>G<sub>ref</sub>
</italic>) + (<italic>C<sub>alt</sub>
</italic> − <italic>C<sub>ref</sub>
</italic> in Equation (<xref ref-type="disp-formula" rid="FD2">2</xref>) represents the varied number of G and C among compared sequences.</p>
</sec>
<sec id="S15">
<title>Clade subgrouping</title>
<p id="P35">To detect trend followers and disrupters in mutation spectra, a pipeline was developed to select such genomes and mutations within clades iteratively. The first step includes locating high-frequency mutations (major alleles, MA) in a clade and extracting all genomes without this MA mutation to form a subset of the clade. The second step is, within the new subclade, to iterate the process until such mutations are thoroughly identified and no more mutations exceed a manually set threshold of MAF. Since the number of unique variations among clades have been varying significantly over time, the thresholds are 0.05 in C01, C04, C06, C08 and C09; 0.1 in C02, C03, C05 and C07. The proportion of permutations in each subclade and the located gene and mutation type (synonymous or non-synonymous) of mutations are provided in <xref ref-type="supplementary-material" rid="SD1">Table S5</xref>.</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplemental files</label>
<media xlink:href="EMS94378-supplement-Supplemental_files.zip" mimetype="application" mime-subtype="zip" id="N67138" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplemental Figures Legends</label>
<media xlink:href="EMS94378-supplement-Supplemental_Figures_Legends.pdf" mimetype="application" mime-subtype="pdf" id="N67147" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S16">
<title>Acknowledgements</title>
<p>This work was supported by grants from The Strategic Priority Research Program of the Chinese Academy of Sciences [XDA19090116 to S.S., XDA19050302 to Z.Z.], National Key R&amp;D Program of China [2020YFC0848900, 2017YFC0907502], 13th Five-year Informatization Plan of Chinese Academy of Sciences [XXH13505-05], K. C. Wong Education Foundation to Z.Z., and International Partnership Program of the Chinese Academy of Sciences [153F11KYSB20160008]. The Youth Innovation Promotion Association of Chinese Academy of Science [2017141 to S.S.]; Funding for open access charge: The Youth Innovation Promotion Association of Chinese Academy of Science. We thank our colleagues and students for their hard working on the 2019nCoVR (<ext-link ext-link-type="uri" xlink:href="https://bigd.big.ac.cn/ncov">https://bigd.big.ac.cn/ncov</ext-link>). We thank Dr. Lina Ma, Lili Hao, and Meng Zhang for useful suggestions and discussion of this manuscript.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="con">
<label>Authoras’ contributions</label>
<p id="P36">JY designed, supervised, and coordinated the study. SS, ZZ and JX participated in the design of the study. XT, QL, ZL, YZ, GN performed the data analysis. JY, SS, XT, QL, ZL, YZ designed and drew the figures. JY and XT drafted the manuscript. JY, ZZ, SS, QL and XT revised the manuscript. All authors read and approved the final manuscript.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<label>Competing interests</label>
<p id="P37">The authors have declared no competing interests.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y-M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z-G</given-names>
</name>
<etal/>
</person-group>
<article-title>A new coronavirus associated with human respiratory disease in China</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<fpage>265</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="web">
<collab>World Health Organization</collab>
<article-title>Coronavirus disease (COVID-2019) situation report - 144</article-title>
<date-in-citation>Jun 12 2020, date last accessed</date-in-citation>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>EHY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<fpage>672</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<volume>382</volume>
<fpage>1177</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>McGoogan</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention</article-title>
<source>JAMA</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<collab>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses</collab>
<article-title>The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2</article-title>
<source>Nat Microbiol</source>
<year>2020</year>
<volume>5</volume>
<fpage>536</fpage>
<lpage>44</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Coronavirus from Patients with Pneumonia in China, 2019</article-title>
<source>N Engl J Med</source>
<year>2020</year>
<volume>382</volume>
<fpage>727</fpage>
<lpage>33</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z-L</given-names>
</name>
</person-group>
<article-title>Origin and evolution of pathogenic coronaviruses</article-title>
<source>Nat Rev Microbiol</source>
<year>2019</year>
<volume>17</volume>
<fpage>181</fpage>
<lpage>92</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Wit</surname>
<given-names>E</given-names>
</name>
<name>
<surname>van Doremalen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Falzarano</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Munster</surname>
<given-names>VJ</given-names>
</name>
</person-group>
<article-title>SARS and MERS: recent insights into emerging coronaviruses</article-title>
<source>Nat Rev Microbiol</source>
<year>2016</year>
<volume>14</volume>
<fpage>523</fpage>
<lpage>34</lpage>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fung</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>DX</given-names>
</name>
</person-group>
<article-title>Human Coronavirus: Host-Pathogen Interaction</article-title>
<source>Annu Rev Microbiol</source>
<year>2019</year>
<volume>73</volume>
<fpage>529</fpage>
<lpage>57</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2020</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y-R</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q-D</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z-S</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y-Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S-D</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H-J</given-names>
</name>
<etal/>
</person-group>
<article-title>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status</article-title>
<source>Mil Med Res</source>
<year>2020</year>
<volume>7</volume>
<fpage>11</fpage>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Surdel</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Vignuzzi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Denison</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and 602 potential therapeutics</article-title>
<source>PLoS Pathog</source>
<year>2013</year>
<volume>9</volume>
<fpage>e1003565</fpage>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmonds</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Rampant C--&gt;U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary 605 Trajectories</article-title>
<source>mSphere</source>
<year>2020</year>
<volume>5</volume>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Giorgio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martignano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Torcia</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Mattiuz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Conticello</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2</article-title>
<source>Sci Adv</source>
<year>2020</year>
<volume>6</volume>
<fpage>eabb5813</fpage>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A scenario on the stepwise evolution of the genetic code</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2007</year>
<volume>5</volume>
<fpage>143</fpage>
<lpage>51</lpage>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A content-centric organization of the genetic code</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2007</year>
<volume>5</volume>
<fpage>1</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>On the organizational dynamics of the genetic code</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2011</year>
<volume>9</volume>
<fpage>21</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The pendulum model for genome compositional dynamics: from the four nucleotides to the twenty amino acids</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2012</year>
<volume>10</volume>
<fpage>175</fpage>
<lpage>80</lpage>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Witte-Orr</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>CMT</given-names>
</name>
<name>
<surname>Bowdish</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Mossman</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses</article-title>
<source>PLoS Pathog</source>
<year>2010</year>
<volume>6</volume>
<fpage>e1000829</fpage>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Totura</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Baric</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon</article-title>
<source>Curr Opin Virol</source>
<year>2012</year>
<volume>2</volume>
<fpage>264</fpage>
<lpage>75</lpage>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crick</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Codon--anticodon pairing: the wobble hypothesis</article-title>
<source>J Mol Biol</source>
<year>1966</year>
<volume>19</volume>
<fpage>548</fpage>
<lpage>55</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The transcript-centric mutations in human genomes</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2012</year>
<volume>10</volume>
<fpage>11</fpage>
<lpage>22</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Distinct contributions of replication and transcription to mutation rate variation of human genomes</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2012</year>
<volume>10</volume>
<fpage>4</fpage>
<lpage>10</lpage>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>GK-S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Passey</surname>
<given-names>DA</given-names>
</name>
<etal/>
</person-group>
<article-title>Compositional gradients in Gramineae genes</article-title>
<source>Genome Res</source>
<year>2002</year>
<volume>12</volume>
<fpage>851</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobry</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Asymmetric substitution patterns in the two DNA strands of bacteria</article-title>
<source>Mol Biol Evol</source>
<year>1996</year>
<volume>13</volume>
<fpage>660</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparative analysis of rodent and small mammal viromes to better understand the wildlife origin of emerging infectious diseases</article-title>
<source>Microbiome</source>
<year>2018</year>
<volume>6</volume>
<fpage>178</fpage>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>LLM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Viral load of SARS-CoV-2 in clinical samples</article-title>
<source>Lancet Infect Dis</source>
<year>2020</year>
<volume>20</volume>
<fpage>411</fpage>
<lpage>2</lpage>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Detection of SARS-CoV-2 in Different Types of Clinical Specimens</article-title>
<source>JAMA</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>O'Toole</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>V</given-names>
</name>
<name>
<surname>McCrone</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Ruis</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology</article-title>
<source>Nat Microbiol</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>On the origin and continuing evolution of SARS-CoV-2</article-title>
<source>National Science Review</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buckland-Merrett</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Data, disease and diplomacy: GISAID's innovative contribution to global health</article-title>
<source>Glob Chall</source>
<year>2017</year>
<volume>1</volume>
<fpage>33</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein</article-title>
<source>Curr Biol</source>
<year>2020</year>
<volume>30</volume>
<fpage>2196</fpage>
<lpage>203 e3</lpage>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<fpage>270</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becerra-Flores</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cardozo</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate</article-title>
<source>Int J Clin Pract</source>
<year>2020</year>
<fpage>e13525</fpage>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniloski</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sanjana</surname>
<given-names>NE</given-names>
</name>
</person-group>
<article-title>The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.06.14.151357</comment>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Theiler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abfalterer</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.04.29.069054</comment>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ojha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rangarajan</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Izard</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.06.12.148726</comment>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses</article-title>
<source>medRxiv</source>
<year>2020</year>
<comment>2020.03.04.20029538</comment>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teymoori-Rad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Samadizadeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tabarraei</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shahbaz</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Tahamtan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Ten challenging questions about SARS-CoV-2 and COVID-19</article-title>
<source>Expert Rev Respir Med</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R41">
<label>[41]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C-M</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S-H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Population genetics of SARS-CoV-2: disentangling sampling bias and clustering infections</article-title>
<source>Genomics Proteomics Bioinformatics</source>
<year>2020</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="R42">
<label>[42]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotten</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kellam</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Al-Rabeeah</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Makhdoom</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Assiri</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study</article-title>
<source>Lancet</source>
<year>2013</year>
<volume>382</volume>
<fpage>1993</fpage>
<lpage>2002</lpage>
</element-citation>
</ref>
<ref id="R43">
<label>[43]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gire</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Goba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Sealfon</surname>
<given-names>RSG</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Kanneh</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak</article-title>
<source>Science</source>
<year>2014</year>
<volume>345</volume>
<fpage>1369</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="R44">
<label>[44]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemey</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Suchard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Reconstructing the initial global spread of a human influenza pandemic: A Bayesian spatial-temporal model for the global spread of H1N1pdm</article-title>
<source>PLoS Curr</source>
<year>2009</year>
<volume>1</volume>
<comment>RRN1031</comment>
</element-citation>
</ref>
<ref id="R45">
<label>[45]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>GJD</given-names>
</name>
<name>
<surname>Vijaykrishna</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bahl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lycett</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Worobey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pybus</surname>
<given-names>OG</given-names>
</name>
<etal/>
</person-group>
<article-title>Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic</article-title>
<source>Nature</source>
<year>2009</year>
<volume>459</volume>
<fpage>1122</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R46">
<label>[46]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>G-D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Corlett</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data</article-title>
<source>Zool Res</source>
<year>2020</year>
<volume>41</volume>
<fpage>247</fpage>
<lpage>57</lpage>
</element-citation>
</ref>
<ref id="R47">
<label>[47]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fritch</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Madden</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Heise</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.06.15.153197</comment>
</element-citation>
</ref>
<ref id="R48">
<label>[48]</label>
<element-citation publication-type="journal">
<collab>National Genomics Data Center M, Partners.</collab>
<article-title>Database Resources of the National Genomics Data Center in 2020</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>D24</fpage>
<lpage>D33</lpage>
</element-citation>
</ref>
<ref id="R49">
<label>[49]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Wo</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>PY</given-names>
</name>
<etal/>
</person-group>
<article-title>The China National GeneBank horizontal line owned by all, completed by all and shared by all</article-title>
<source>Hereditas(Beijing)</source>
<year>2019</year>
<volume>41</volume>
<fpage>761</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="R50">
<label>[50]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayers</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Cavanaugh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ostell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pruitt</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Karsch-Mizrachi</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>GenBank</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>D84</fpage>
<lpage>D6</lpage>
</element-citation>
</ref>
<ref id="R51">
<label>[51]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Desmeth</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>McCluskey</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>World data centre for microorganisms: an information infrastructure to explore and utilize preserved microbial strains worldwide</article-title>
<source>Nucleic Acids Res</source>
<year>2017</year>
<volume>45</volume>
<fpage>D611</fpage>
<lpage>D8</lpage>
</element-citation>
</ref>
<ref id="R52">
<label>[52]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>
<source>Nucleic Acids Res</source>
<year>2004</year>
<volume>32</volume>
<fpage>1792</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R53">
<label>[53]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stecher</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knyaz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms</article-title>
<source>Mol Biol Evol</source>
<year>2018</year>
<volume>35</volume>
<fpage>1547</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R54">
<label>[54]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Astell</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Brooks-Wilson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Butterfield</surname>
<given-names>YS</given-names>
</name>
<etal/>
</person-group>
<article-title>The Genome sequence of the SARS-associated coronavirus</article-title>
<source>Science</source>
<year>2003</year>
<volume>300</volume>
<fpage>1399</fpage>
<lpage>404</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>[55]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Riat</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>GRS</given-names>
</name>
<name>
<surname>Thormann</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>The Ensembl Variant Effect Predictor</article-title>
<source>Genome Biol</source>
<year>2016</year>
<volume>17</volume>
<fpage>122</fpage>
</element-citation>
</ref>
<ref id="R56">
<label>[56]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Dehal</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Arkin</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>FastTree 2--approximately maximum-likelihood trees for large alignments</article-title>
<source>PLoS One</source>
<year>2010</year>
<volume>5</volume>
<fpage>e9490</fpage>
</element-citation>
</ref>
<ref id="R57">
<label>[57]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Letunic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Interactive Tree Of Life (iTOL) v4: recent updates and new developments</article-title>
<source>Nucleic Acids Res</source>
<year>2019</year>
<volume>47</volume>
<fpage>W256</fpage>
<lpage>W9</lpage>
</element-citation>
</ref>
<ref id="R58">
<label>[58]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schliep</surname>
<given-names>KP</given-names>
</name>
</person-group>
<article-title>phangorn: phylogenetic analysis in R</article-title>
<source>Bioinformatics</source>
<year>2011</year>
<volume>27</volume>
<fpage>592</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R59">
<label>[59]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Using ggtree to Visualize Data on Tree-Like Structures</article-title>
<source>Curr Protoc Bioinformatics</source>
<year>2020</year>
<volume>69</volume>
<fpage>e96</fpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>A display of genome compositional dynamics of SARS-CoV-2 and related CoVs</title>
<p>
<bold>A.</bold> The complete genome sequence of SARS-CoV-2 (NC_045512.2), including both structural and non-structural components. <bold>B.</bold> We use a 300-nt sliding window with a 21-nt step to show dynamic changes of genome G+C, purine, GC1 to GC3, and GC skew (G-C/G+C) contents over the entire genomes. <bold>C.</bold> A similar procedure as described above is applied to individual ORFs and proteins. Note that the GC skews are not uniform over the genome length and the observation suggests possible recent recombination among closely related CoVs.</p>
</caption>
<graphic xlink:href="EMS94378-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Nucleobase contents of genomes and subgenomes of SARS-CoV-2 and related CoVs</title>
<p>
<bold>A.</bold> A schematic phylogenetic tree is used to cluster genome sequences and compositional variables (15 CoVs genome sequences, from top to bottom, are: hsa-betaCoV-HKU1, hsa-betaCoV-OC43, ave-gamaCoV, mga-gamaCoV, smu-alphaCoV-WS, hsa-alphaCoV-229E, hsa-alphaCoV-NL63, taf-alphaCoV-NL63, MERS-CoV, cdr-betaCoV-B73, SARS-CoV, pla-betaCoV-SZ3, mja-betaCoV-P4L, SARS-CoV-2, and raf-betaCoV-RaTG13). These compositional variables include GC contents at three codon positions (codon positions 1, 2, and 3 are denoted as GC1, GC2, and GC3) and single nucleotide contents at three codon positions (A1, A2, A3; U1, U2, U3; G1, G2, G3; and C1, C2, C3). Nucleotides are labeled in different shapes: purines, triangles; pyrimidines, open circles. A and U or G and C are colored blue or red, respectively. It becomes obvious that the two closely-related CoV genomes to SARS-CoV-2, the reported bat (raf-betaCoV-RaTG13) and the pangolin (mja-betaCoV-P4L) have very similar codon G+C content as well as base contents. The cp1 (codon position 1) base content appears most characteristic of balanced purine content of SARS-CoV-2 and its close relatives. The cp2 (codon position 2) base content of SARS-CoV-2 and all other CoVs has higher and relatively balanced A+U content. The older human CoVs have either lowest or higher G+C content and unbalanced purine contents. Note that G+C contents in three codon positions are labeled differently from those of single nucleotide contents in color codes. G+C content represents a single measure but single nucleotide contents demonstrate trends of all four nucleotides. <bold>B.</bold> The G+C and single nucleotide contents at different codon positions of complete genomes and subgenomes of SARS-CoV-2, SARS-CoV, mja-betaCoV-P4L, and raf-betaCoV-RaTG13 are displayed to illustrate the driving force for G+C content decrease toward 3' end of the genome, which is rather a result of, in terms of mechanism, the increased U content and C-to-U permutation. The negative gradient of U is also obvious from the 5' end to the 3' end.</p>
</caption>
<graphic xlink:href="EMS94378-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Mutation spectra of SARS-CoV-2 in a context of G+C contents and codon positions</title>
<p>
<bold>A.</bold> The SARS-CoV-2 mutation spectrum is composed of 12 permutations and they are divided by codon positions among all mutations. C-to-U (CU), U-to-C (UC), A-to-G (AG), G-to-A (GA), and G-to-U (GU), are always dominant due to two principles; one is that the first four permutations occur when positive-sense genome is synthesized, and the other is that a G-by-A replacement is always preferred by RTCs so that G-to-U permutation as the most dominant occurring when the antigenome serves as a template. <bold>B.</bold> C-to-U permutations at cp3 diminish among non-synonymous mutations and this phenomenon indicates that most protein composition relevant variations are cp1 and cp2 variations. The remaining non-synonymous mutations in G-to-U (GU) permutation may be a result of biased strand synthesis. <bold>C.</bold> Displays of permutation-to-codon changes among non-synonymous mutations. The codon table is divided into two halves: the pro-diversity half (blue) whose cp3 is sensitive to transitional change and the pro-robust half (purple) whose cp3 position is insensitive to any change. Two examples, C-to-U (1051 in counts) and A-to-G (314 in counts) permutations are shown here. When a codon has a C-to-U change, the codon position varies, results of such changes relative to codon positions are summarized on both sides of the codon flow chart. Note that cp1 and cp2 changes appear more than those of cp3. The ratio between codons of pro-robust half and pro-diversity half is displayed on each bar. <bold>D.</bold> All permutations are plotted against the reference genome sequence to show how changes are related to amino acids. In the molecular weight index, most cp1 and cp2 changes are most obvious, showing an increasing trend. In the hydrophobicity index, most cp1 and cp2 changes increase toward less hydrophobicity.</p>
</caption>
<graphic xlink:href="EMS94378-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Sequence-variation-based phylogenies of SARS-CoV-2</title>
<p>
<bold>A.</bold> CoV genomes are divided into clades and clade clusters based on high-frequency mutations among the genome sequences. The shared variations are excellent indicators for shared ancestors and those between clusters (blue half parentheses) and within clusters (red half parentheses) are labeled with positions and nucleotide variations that are all referenced to the SARS-CoV-2 genome (NC_045512.2), its positions, and relative frequencies (thin vertical bars). The dates when each clade started are also indicated. <bold>B.</bold> The current collection shows 9 clades (C01 to C09) in three clusters (S, L and G). An unrooted phylogenic tree of the clades and clusters (color-coded), the tree scale is 0.01.</p>
</caption>
<graphic xlink:href="EMS94378-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Mutation spectrum and composition dynamics among 9 SARS-CoV-2 clades</title>
<p>
<bold>A.</bold> Plots showing permutation variation of each clade. Aside from the 5 dominant permutations, A-to-C (R2 permutation), U-to-G (R2 permutation) and A-to-U (R12 permutation) changes appear also significant; such an increase in proportion of R2 and R12 permutations often indicates copy number (synthesis) bias between the two strands. <bold>B.</bold> When permutations are grouped based on structure-conformation model (<xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>) into tight and loose groups (a four-parameter model), their trends of changes become obvious. The R-tight discourages A-by-G replacement but encourages C-by-U replacement when the genome is replicated. The loose statuses, regardless R-loose or Y-loose, place no pressure on permutation variability. <bold>C</bold>. Violin plots showing the G+C content among clades. <bold>D</bold>. Violin plots showing the purine content among the clades. C08 and C09 have been drifting both contents toward lower ends. C03 has also been drifting in a greater extent of its purine content and a lesser extent of its G+C content, comparatively. <bold>E.</bold> The mean (solid circles) and median (solid triangles) of G+C and purine contents among clades. The same three more expressive clades, as seen in (<bold>C</bold>) and (<bold>D</bold>), are indeed obvious (inset). <bold>F.</bold> The compositional dynamics of cp3 nucleotides that are less selected and with a stringent cutoff value (&gt; or =5). <bold>G.</bold> Composition distributions based on major alleles, at frequencies equal or greater than 0.01 to emphasize the effect from selection. <bold>H</bold>. Composition distributions based on major alleles at frequencies equal or greater than 0.05. <bold>I</bold>. Composition distributions based on major alleles at frequencies equal or greater than 0.1.</p>
</caption>
<graphic xlink:href="EMS94378-f005"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<title>Within-clade permutation variations are excellent indicators of functional mutations</title>
<p>
<bold>A.</bold> An example of permutation shifting of clade C02 and among its subclades. The number of SARS-CoV-2 genomes is indicated in the parentheses. The clear trends are two-fold. First, decreased C-to-U permutation is coupled with increased A-to-G and decreased G-to-U permutations. Second, A-to-U permutation is also increased as expected based on the model shown in <xref ref-type="supplementary-material" rid="SD1">Figure S5</xref>. These trends pf permutation changes suggest irrelevant to the ratio of strand-biased synthesis (positive sense vs negative sense) but possible structural and/or conformational variation in the RTCs. <bold>(B)</bold> - <bold>(F)</bold> show within-clade permutation changes of C02, C04, C03, C05 and C07. In each display, the first column of the x-axis shows the proportion of permutations calculated for each clade. Two opposite trends of permutation variations are seen between C03 and C04, and C07 has a rather wavy pattern.</p>
</caption>
<graphic xlink:href="EMS94378-f006"/>
</fig>
</floats-group>
</article>
